Nicotinamide N-Methyltransferase (NNMT): A New Hope for Treating Aging and Age-Related Conditions

Jing-Jing Li,Wei-Dong Sun,Xiao-Juan Zhu,Ya-Zhong Mei,Wen-Song Li,Jiang-Hua Li

DOI: https://doi.org/10.3390/metabo14060343

IF: 4.1

2024-06-19

Metabolites

Abstract:The complex process of aging leads to a gradual deterioration in the function of cells, tissues, and the entire organism, thereby increasing the risk of disease and death. Nicotinamide N-methyltransferase (NNMT) has attracted attention as a potential target for combating aging and its related pathologies. Studies have shown that NNMT activity increases over time, which is closely associated with the onset and progression of age-related diseases. NNMT uses S-adenosylmethionine (SAM) as a methyl donor to facilitate the methylation of nicotinamide (NAM), converting NAM into S-adenosyl-L-homocysteine (SAH) and methylnicotinamide (MNA). This enzymatic action depletes NAM, a precursor of nicotinamide adenine dinucleotide (NAD+), and generates SAH, a precursor of homocysteine (Hcy). The reduction in the NAD+ levels and the increase in the Hcy levels are considered important factors in the aging process and age-related diseases. The efficacy of RNA interference (RNAi) therapies and small-molecule inhibitors targeting NNMT demonstrates the potential of NNMT as a therapeutic target. Despite these advances, the exact mechanisms by which NNMT influences aging and age-related diseases remain unclear, and there is a lack of clinical trials involving NNMT inhibitors and RNAi drugs. Therefore, more in-depth research is needed to elucidate the precise functions of NNMT in aging and promote the development of targeted pharmaceutical interventions. This paper aims to explore the specific role of NNMT in aging, and to evaluate its potential as a therapeutic target.

biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of nicotinamide N - methyltransferase (NNMT) in aging and its related diseases, and to evaluate its potential as a therapeutic target. Specifically, the paper focuses on the following aspects:

1. **The relationship between NNMT and NAD+ and Hcy metabolism**:
- NNMT catalyzes the methylation of nicotinamide (NAM) by using S - adenosylmethionine (SAM) as a methyl donor, generating S - adenosyl - L - homocysteine (SAH) and methylnicotinamide (MNA). This process leads to the consumption of NAM and the generation of SAH, which in turn affects the NAD+ level and the homocysteine (Hcy) level.
- The paper points out that the decrease in NAD+ level and the increase in Hcy level are considered important factors in aging and age - related diseases.

2. **The relationship between increased NNMT activity and age - related diseases**:
- Research shows that the expression and activity of NNMT increase with age, which is closely related to the onset and development of multiple age - related diseases, such as neurodegenerative diseases, diabetes, cardiovascular diseases, and cancer.
- For example, the NNMT gene expression in the liver cells of old mice is significantly increased; inhibiting the NNMT activity in old mice can activate senescent muscle stem cells and promote muscle regeneration.

3. **The potential of NNMT as a therapeutic target**:
- Although previous studies have shown that RNA interference (RNAi) therapy and small - molecule inhibitors are effective in targeting NNMT, their exact mechanisms are still not fully understood, and there is a lack of clinical trial data.
- The paper aims to deeply study the specific role of NNMT in aging, evaluate its potential as a therapeutic target, and propose new research ideas for preventing and controlling aging.

In conclusion, this paper mainly explores the mechanism of NNMT in aging and age - related diseases and evaluates its possibility as a potential therapeutic target.